The grants awarded are summarized below:
12.31.2017 in thousands of options |
|
|
||||||||||||||||||||||||||
Weighted | Weighted | |||||||||||||||||||||||||||
average | average | |||||||||||||||||||||||||||
Grants | Exercised | Canceled (i) | Outstanding | Exercible | exercise Price (R$) |
exercise Price (US$) |
||||||||||||||||||||||
Grants on January 23, 2012 |
4,860,000 | (2,893,160 | ) | (1,009,100 | ) | 957,740 | 957,740 | 11.50 | 6.56 | |||||||||||||||||||
Grants on March 20, 2013 |
4,494,000 | (802,135 | ) | (1,263,490 | ) | 2,428,375 | 1,436,255 | 15.71 | 7.91 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
At December 31, 2017 |
9,354,000 | (3,695,295 | ) | (2,272,590 | ) | 3,386,115 | 2,393,995 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(i) | The cancellations refer to shares granted to executives or employees who no longer work for the Company. Additionally, on April 16, 2014, there was a cancellation of the grants awarded to members of the Board of Directors, with payment of compensation to plan participants. |